Anubha Agarwal1, Padinhare P Mohanan2, Dimple Kondal3, Abigail Baldridge4, Divin Davies2, Raji Devarajan3, Govindan Unni5, Jabir Abdullakutty6, Syam Natesan7, Johny Joseph8, Pathiyil B Jayagopal9, Stigi Joseph10, Rajesh Gopinath11, Mark D Huffman12, Dorairaj Prabhakaran13. 1. Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: anubha.agarwal@northwestern.edu. 2. WestFort Hi-Tech Hospital, Thrissur, Kerala, India. 3. Centre for Chronic Disease Control, New Delhi, Delhi, India. 4. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 5. Jubilee Mission Medical College and Hospital, Thrissur, Kerala, India. 6. Lisie Hospital, Kochi, Kerala, India. 7. Kollam District Hospital, Kollam, Kerala, India. 8. Caritas Hospital, Kottayam, Kerala, India. 9. Lakshmi Hospital, Palakkad, Kerala, India. 10. Little Flower Hospital and Research Centre, Angamaly, Kerala, India. 11. Amala Institute of Medical Sciences, Thrissur, Kerala, India. 12. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia. 13. Centre for Chronic Disease Control, New Delhi, Delhi, India; The Public Health Foundation of India, Gurugram, Haryana, India.
Abstract
BACKGROUND: Although quality improvement interventions for acute heart failure have been studied in high-income countries, none have been studied in low- or middle-income country settings where quality of care can be lower. We evaluated the effect of a quality improvement toolkit on process of care measures and clinical outcomes in patients hospitalized for acute heart failure in 8 hospitals in Kerala, India utilizing an interrupted time series design from February 2018 to August 2018. METHODS: The quality improvement toolkit included checklists, audit-and-feedback reports, and patient education materials. The primary outcome was rate of discharge guideline-directed medical therapy for patients with heart failure with reduced ejection fraction. We used mixed effect logistic regression and interrupted time series models for analysis. RESULTS: Among 1400 participants, mean (SD) age was 66.6 (12.2) years, and 38% were female. Mean (SD) left ventricular ejection fraction was 35.2% (9.7%). The primary outcome was observed in 41.3% of participants in the intervention period and 28.1% of participants in the control period (difference 13.2%; 95% CI 6.8, 19.0; adjusted OR = 1.70; 95% CI 1.17, 2.48). Interrupted time series model demonstrated highest rate of guideline-directed medical therapy at discharge in the initial weeks following intervention delivery with a concomitant decline over time. Improvements were observed in discharge process of care measures, including diet counseling, weight monitoring instructions, and scheduling of outpatient clinic follow-up but not hospital length of stay nor inpatient mortality. CONCLUSIONS: Higher rates of guideline-directed medical therapy at discharge were observed in Kerala. Broader implementation of this quality improvement intervention may improve heart failure care in low- and middle-income countries.
BACKGROUND: Although quality improvement interventions for acute heart failure have been studied in high-income countries, none have been studied in low- or middle-income country settings where quality of care can be lower. We evaluated the effect of a quality improvement toolkit on process of care measures and clinical outcomes in patients hospitalized for acute heart failure in 8 hospitals in Kerala, India utilizing an interrupted time series design from February 2018 to August 2018. METHODS: The quality improvement toolkit included checklists, audit-and-feedback reports, and patient education materials. The primary outcome was rate of discharge guideline-directed medical therapy for patients with heart failure with reduced ejection fraction. We used mixed effect logistic regression and interrupted time series models for analysis. RESULTS: Among 1400 participants, mean (SD) age was 66.6 (12.2) years, and 38% were female. Mean (SD) left ventricular ejection fraction was 35.2% (9.7%). The primary outcome was observed in 41.3% of participants in the intervention period and 28.1% of participants in the control period (difference 13.2%; 95% CI 6.8, 19.0; adjusted OR = 1.70; 95% CI 1.17, 2.48). Interrupted time series model demonstrated highest rate of guideline-directed medical therapy at discharge in the initial weeks following intervention delivery with a concomitant decline over time. Improvements were observed in discharge process of care measures, including diet counseling, weight monitoring instructions, and scheduling of outpatient clinic follow-up but not hospital length of stay nor inpatient mortality. CONCLUSIONS: Higher rates of guideline-directed medical therapy at discharge were observed in Kerala. Broader implementation of this quality improvement intervention may improve heart failure care in low- and middle-income countries.
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: J Am Coll Cardiol Date: 2013-06-05 Impact factor: 24.094
Authors: Adam D DeVore; Margueritte Cox; Paul A Heidenreich; Gregg C Fonarow; Clyde W Yancy; Zubin J Eapen; Eric D Peterson; Adrian F Hernandez Journal: Circ Cardiovasc Qual Outcomes Date: 2015-07-14
Authors: Daniel Levy; Satish Kenchaiah; Martin G Larson; Emelia J Benjamin; Michelle J Kupka; Kalon K L Ho; Joanne M Murabito; Ramachandran S Vasan Journal: N Engl J Med Date: 2002-10-31 Impact factor: 91.245
Authors: Wendy A Gattis; Christopher M O'Connor; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade Journal: J Am Coll Cardiol Date: 2004-05-05 Impact factor: 24.094
Authors: Gregory A Roth; Mark D Huffman; Andrew E Moran; Valery Feigin; George A Mensah; Mohsen Naghavi; Christopher J L Murray Journal: Circulation Date: 2015-10-27 Impact factor: 29.690
Authors: Margaret E Kruk; Anna D Gage; Naima T Joseph; Goodarz Danaei; Sebastián García-Saisó; Joshua A Salomon Journal: Lancet Date: 2018-09-05 Impact factor: 79.321
Authors: Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Mihai Gheorghiade; Yang Liu; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary N Walsh; Clyde W Yancy Journal: J Am Heart Assoc Date: 2012-02-20 Impact factor: 5.501